N3 HNSCC: outcomes poor despite treatment intensification

Access to the full content of this site is available only to registered healthcare professionals. Register to read more


  • Patients with N3 head and neck squamous cell carcinoma (HNSCC) treated with very accelerated radiotherapy (VART) or concurrent chemoradiotherapy (CCRT) had 5-y OS of 13.8%.

Why this matters

  • Outcomes of N3 patients have not been widely reported.

Key results

  • 2-y OS wa...